Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity.

× No keyword cloud information.

15 in total

Review 1. The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors: K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal: Handb Exp Pharmacol Date: 2017

Review 2. Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.

Authors: H R Masure; R L Shattuck; D R Storm
Journal: Microbiol Rev Date: 1987-03

3. Agar diffusion method for the differentiation of Bacillus anthracis.

Authors: L H Angelety; G G Wright
Journal: Appl Microbiol Date: 1971-01

4. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Authors: Manuel Osorio; Yanping Wu; Sunil Singh; Tod J Merkel; Siba Bhattacharyya; Milan S Blake; Dennis J Kopecko
Journal: Infect Immun Date: 2009-01-29 Impact factor: 3.441

5. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors: J W Ezzell; B E Ivins; S H Leppla
Journal: Infect Immun Date: 1984-09 Impact factor: 3.441

6. Metabolic changes in nicotinamide adenine dinucleotide in response to anthrax toxin.

Authors: I Gray; L J Archer
Journal: J Bacteriol Date: 1967-01 Impact factor: 3.490

7. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors: S H Leppla
Journal: Proc Natl Acad Sci U S A Date: 1982-05 Impact factor: 11.205

8. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.

Authors: Sarah C Taft; Alison A Weiss
Journal: Clin Vaccine Immunol Date: 2007-11-21

9. Purification and properties of in vitro-produced anthrax toxin components.

Authors: D C Fish; B G Mahlandt; J P Dobbs; R E Lincoln
Journal: J Bacteriol Date: 1968-03 Impact factor: 3.490

10. Elaboration of Bacillus anthracis antigens in a new, defined culture medium.

Authors: J D Ristroph; B E Ivins
Journal: Infect Immun Date: 1983-01 Impact factor: 3.441